Impact of Exercise-derived Extracellular Vesicle in Blood and Physical Fitness Data in Overweight/Obesity Individuals (Exercise)

December 16, 2025 updated by: Mahidol University

Exploring the Impact of Exercise-derived Extracellular Vesicle in Blood and Physical Fitness Data in Overweight/Obesity Individuals on Lymphangiogenesis

This project aims to study the effect of exercise in the obesity/overweight on the changes of physical fitness and blood components. This will provide novel knowledge for medical staffs, researchers, or companies developing alternative strategies for treating obesity/overweight, including drug development and health promotion project to delay or prevent the onset of the disease.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Mueang Samut Prakan, Thailand, 10540
        • Recruiting
        • Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Male or female individuals aged between 25-45 years
  2. Thai nationality
  3. Ability to walk or perform daily activities independently, without the use of an assistive device
  4. Body mass index (BMI) between 25-35 kg/m²
  5. Low physical activity levels or sedentary lifestyle based on the World Health Organization 2020

    • The levels of moderate-intensity physical activity < 150-300 minutes per week or the levels of vigorous-intensity physical activity < 75-150 minutes per week
    • Moderate-intensity physical activity: fast walking and bicycling. Vigorous-intensity physical activity: running, aerobic dance, and swimming All participants are required to meet all inclusion criteria to be eligible for the research project.

Exclusion Criteria:

  1. Smoking, substance abuse, or alcohol addiction
  2. History of respiratory diseases, such as asthma, emphysema, or chronic obstructive pulmonary disease
  3. History of cardiovascular diseases, such as coronary heart disease, aortic disease, arrhythmia, or deep vein thrombosis
  4. History of high blood pressure (hypertension)
  5. History of vestibular system diseases, such as Meniere's disease or otitis media
  6. History of neurological disease, such as severe Parkinson's disease or stroke
  7. History of previous lower limb surgery, such as hip, knee, or ankle replacement
  8. History of musculoskeletal diseases, such as severe osteoarthritis
  9. History of severe brain disease, such as dementia
  10. Severe visual or hearing impairment
  11. Have a cognitive and comprehensive impairment and unable to complete the intervention
  12. Have high physical activity or regularly exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-intensity interval training exercise
High-intensity interval training exercise 3 days per week for 6 weeks
High-intensity interval training exercise using 65% to 80% of heart rate max
Other Names:
  • HIIT
  • treadmill running

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood component assessment
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program within 1 hour)
Participant's blood components, e.g. extracellular vesicles, will be investigated by cell assays and proteomic analysis
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program within 1 hour)
Foot pressure distribution
Time Frame: 8 times: Day 1 (Before and after HIIT program), Day 4-7 (after HIIT program only), Day 18 (Before and after HIIT program)
Foot pressure distribution will be measured using a treadmill (Zebris FDM-T Treadmill System, zebris Medical GmbH, Germany)
8 times: Day 1 (Before and after HIIT program), Day 4-7 (after HIIT program only), Day 18 (Before and after HIIT program)
Facial and abdominal fat thickness measurement
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Facial and abdominal fat thickness and characteristics will be pictured and analyzed using ultrasound imaging
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
VO2max
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
VO2max parameter (ml/kg/min) will be examined using Cardio Pulmonary Exercise Test
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Body composition
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Body composition (%) will be measured by bioelectrical impedance analysis.
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Heart rate
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Heart rate (beat/min) will be measured by pulse oximeters
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Grip strength
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Grip strength (kg) will be measured by hand grip dynamometer
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Leg strength
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Leg strength (kg) will be measured by back-leg-chest dynamometer
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Body weight
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Body weight (kg) will be measured by weighing scale
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
Body height
Time Frame: Pre-training (Day 1 before HIIT program)
Body height (cm) will be measured by stadiometer
Pre-training (Day 1 before HIIT program)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2025

Primary Completion (Estimated)

January 31, 2026

Study Completion (Estimated)

January 31, 2026

Study Registration Dates

First Submitted

November 30, 2025

First Submitted That Met QC Criteria

December 16, 2025

First Posted (Actual)

December 31, 2025

Study Record Updates

Last Update Posted (Actual)

December 31, 2025

Last Update Submitted That Met QC Criteria

December 16, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • MURA2025/678
  • 2025/1365 (Registry Identifier: Mahidol University Multi-faculty Cooperative IRB Review)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity & Overweight

Clinical Trials on High-intensity interval training exercise on treadmill

Subscribe